Moreover, other data indicate that CRP>10 mg/L is possibly linked to resistance to IL-2 therapy, and it is possible that genetic variations underlying overweight and elevated CRP also contribute to worse melanoma patient survival [850,851]. This evidence concerns the gene CRP and melanoma.